CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 71 filers reported holding CABALETTA BIO INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,566,792 | +241.7% | 300,052 | +85.7% | 0.00% | – |
| Q1 2023 | $1,336,399 | +18991.4% | 161,596 | +1369.6% | 0.00% | – |
| Q3 2022 | $7,000 | -53.3% | 10,996 | -21.1% | 0.00% | – |
| Q2 2022 | $15,000 | -46.4% | 13,945 | +0.6% | 0.00% | – |
| Q1 2022 | $28,000 | -44.0% | 13,859 | +5.2% | 0.00% | – |
| Q4 2021 | $50,000 | -90.4% | 13,174 | -69.3% | 0.00% | – |
| Q3 2021 | $522,000 | +71.7% | 42,967 | +21.5% | 0.00% | – |
| Q2 2021 | $304,000 | -39.0% | 35,373 | -21.2% | 0.00% | – |
| Q1 2021 | $498,000 | +26.7% | 44,887 | +42.6% | 0.00% | – |
| Q4 2020 | $393,000 | +44.5% | 31,480 | +25.6% | 0.00% | – |
| Q3 2020 | $272,000 | -14.7% | 25,069 | -12.3% | 0.00% | – |
| Q2 2020 | $319,000 | +72.4% | 28,600 | +13.0% | 0.00% | – |
| Q1 2020 | $185,000 | – | 25,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |